Toronto, Canada

Ming Chen

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Institut Curie. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ming Chen. Retrieved from https://idiyas.com/inventor/ming-chen-x1tdtgif

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ming Chen

Introduction

Ming Chen is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of stable cell lines expressing the CFTR protein. His work has implications for understanding cystic fibrosis and related diseases.

Latest Patents

Ming Chen holds one patent titled "Stable cell lines expressing the CFTR protein or a mutant of this." This invention relates to a recombinant nucleic acid, characterized by its unique composition that aids in the study of CFTR protein functionality.

Career Highlights

Throughout his career, Ming Chen has worked with prestigious institutions such as Institut Curie and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Ming Chen has collaborated with esteemed colleagues, including Marie-Alyette Costa De Beauregard and Daniel Louvard. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Ming Chen's innovative work in biotechnology, particularly his patent on stable cell lines, showcases his dedication to advancing scientific knowledge. His collaborations and career achievements further highlight his importance in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…